As a disease with complex heterogeneity, TNBC not only lacks the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 at hormone level, but also shows more diversity at molecular genetic level compared with other subtypes of breast cancer (Kalimutho et al., 2015). This evidence concerns the gene PGR and breast carcinoma.